Abstract
The article presents material on chronic thromboembolic pulmonary hypertension (CTEPH), which is one of the forms of pulmonary hypertension. The main cause of the development of CTEPH is pulmonary embolism. It is well known that pulmonary embolism ranks third in the structure of cardiovascular mortality after heart attack and stroke. The basis of the pathogenesis of the development of CTEPH is the process in which organized thrombotic masses cause stenosis or obstruction of the pulmonary artery. This form of pulmonary hypertension is potentially curable with surgery. This article presents the evolution of views from its origins to the present. The most modern diagnostic, surgical and therapeutic methods for treating this disease are presented. Our own experience is briefly presented, as well as a discussion in the light of modern literature.
References
-
Kim N.H., Delcroix M., Jais X, Madani М.М., Matsubara H., Mayer E. et al. Chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019; 53: 1801915. DOI: 10.1183/13993003.01915-2018
-
Gillinov A.M., Gelijns A.C., Parides M.K., DeRose J.J. Jr., Moskowitz A.J., Voisine P. et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N. Engl. J. Med. 2015; 372 (15): 1399–1409. DOI: 10.1056/NEJMoa1500528
-
Fedullo P.F., Auger W.R., Kerr K.M., Rubin L.J. Chronic thromboembolic pulmonary hypertension. N. Engl. J. Med. 2001; 345: 1465–1472. DOI: 10.1056/NEJMra010902
-
Chernyavsky A.M., Edemsky A.G., Novikova N.V., Pak N.T., Nartsissova G.P., Zavadovsky K.V. et al. Surgical treatment of chronic thromboembolic pulmonary hypertension; under general ed. A.M. Chernyavsky. Novosibirsk; 2019 (in Russ.).
-
Chazova I.E., Martynyuk T.V., Valieva Z.S., Azizov V.A., Akchurin R.S. et al. Eurasian Association of Cardiology (EAC) guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (2020). Eurasian Heart Journal. 2021; (1): 6–43 (in Russ.). DOI: 10.38109/2225-1685-2021-1-6-43
-
Gall H., Hoeper M.M., Richter M.J., Cacheris W., Hinzmann B., Mayer E. An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan. Eur. Respir. Rev. 2017; 26 (143): 160121. DOI: 10.1183/16000617.0121-2016
-
Coquoz N., Weilenmann D., Stolz D., Popov V., Azzo I.A., Fellrath J.M. et al. Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism. Eur. Respir. J. 2018; 51 (4): 1702505. DOI: 10.1183/13993003.02505-2017
- Lang I.M., Dorfmüller P., Vonk Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann. Am. Thorac. Soc. 2016; 13 (Suppl. 3): S215–21. DOI: 10.1513/AnnalsATS.201509-620AS
-
Chernyavskiy A.M., Novikova N.V., Edemskiy A.G., Chernyavskiy M.A., Tarkova A.R. Chronic postembolic pulmonary hypertension: difficult aspects of diagnosis and treatment. Medical Alphabet. 2015; 10 (2): 5–9 (in Russ.).
-
Jamieson S.W., Kapelanski D.P., Sakakibara N., Channick N.R., Fedullo P.F., Auger W.R. et al. Pulmonary endarterectomy: Experience and lessons learned in 1,500 cases. Ann. Thorac. Surg. 2003; 76: 1457–1462. DOI: 10.1016/s0003-4975(03)00828-2
-
Jenkins D.P., Madani M., Mayer E., Kerr K., Kim N., Klepetko W. et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2013; 41 (3): 735–742. DOI: 10.1183/09031936.00058112
-
Lungdahl M.T. Gibteseine chronic heembolisierg der lungen arterie. Deutsches Arch. Klin. Med. 1928: 160.
-
Moser K.M., Rhodes P.G., Hufnagel C.C. Hronic unilateral pulmonary-artery thrombosis: successful thrombendarectomy with thirty-month follow-up observation. N. Engl. J. Med. 1965; 272: 1195–1199. DOI: 10.1056/nejm196506102722302
-
Moser K.M., Houk V.N., Jones R.C., Hufnagel C.C. Chronic, massive thrombotic obstruction of the pulmonary arteries. Analysis of four operated cases. Circulation. 1965; 32 (3): 377–385. DOI: 10.1161/01.cir.32.3.377
-
Chitwood W.R., Sabiston D.C., Wechsler A.S. Surgical treatment of chronic unresolved pulmonary embolism. Clin. Chest Med. 1984; 5:
About the authors
- Igor E. Chernogrivov, Dr. Med. Sci., Head of Department of Surgical Treatment of Heart Diseases with Progressive Pulmonary Hypertension; ORCID
- Sergey V. Gorbachevskiy, Dr. Med. Sci., Professor; ORCID
- Anton А. Shmalts, Dr. Med. Sci., Leading Researcher; ORCID
